التفاصيل البيبلوغرافية
| العنوان: |
Purified Dry Paullinia cupana (PC-18) Extract for Chemotherapy-Induced Fatigue: Results of Two Double-Blind Randomized Clinical Trials. |
| المؤلفون: |
Sette, Claudia Vaz de Melo, Ribas de Alcântara, Bárbara Bonaparte, Schoueri, Jean Henri Maselli, Cruz, Felipe Melo, Cubero, Daniel de Iracema Gomes, Pianowski, Luiz Francisco, Peppone, Luke Joseph, Fonseca, Fernando, del Giglio, Auro |
| المصدر: |
Journal of Dietary Supplements; 2018, Vol. 15 Issue 5, p673-683, 11p |
| مصطلحات موضوعية: |
BREAST tumor diagnosis, CANCER chemotherapy, CANCER patients, COMBINED modality therapy, STATISTICAL correlation, DIETARY supplements, EXERCISE, FATIGUE (Physiology), FROZEN tissue sections, MAGNESIUM, MULTIVARIATE analysis, ORAL drug administration, QUESTIONNAIRES, PLANT extracts, RANDOMIZED controlled trials, BLIND experiment, RETROSPECTIVE studies, MAGNESIUM silicates, EARLY detection of cancer |
| مستخلص: |
Fatigue is frequent among oncologic patients. Unpurified Paullinia cupana dry extract showed encouraging results for chemotherapy-induced fatigue in our previous studies. We report two randomized, double-blind studies with a standardized dry purified Paullinia cupana extract named PC-18. For both studies, we recruited early breast cancer patients who had an increase in their fatigue scores after their first cycle of adjuvant chemotherapy. In the first study, we compared an oral dose of 37.5 mg of PC-18 twice daily with placebo. In the second study, we examined PC-18 at either 7.5 or 12.5 mg orally twice daily versus placebo. In both studies, PC-18 was not superior to placebo as assessed by both Chalder and Brief Fatigue Inventory (BFI) fatigue questionnaires, probably reflecting unexpectedly good placebo antifatigue activity. Since all capsules employed in both studies contained about 100 mg of magnesium silicate as an excipient, we retrospectively evaluated frozen serum samples from the second study and found a significant increase in magnesium levels after patients received placebo. By multivariate analysis, higher prerandomization magnesium levels and higher BFI scores together with the use of a 12.5 mg dose of PC-18 all correlated significantly with higher posttreatment BFI scores. We observed no significant toxicities in any of the trials. We conclude that the absence of differences between PC-18 and placebo may be due to the unexpectedly high antifatigue activity of the placebo in these studies. Further studies evaluating the role of magnesium supplementation for chemotherapy-induced fatigue are needed. [ABSTRACT FROM AUTHOR] |
|
Copyright of Journal of Dietary Supplements is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |